Mural Oncology ends clinical development, lays off most workers

Boston and Dublin biotech Mural Oncology is laying off nearly all of its employees and ending clinical development of its IL-2 drug nemvaleukin alfa. The biotech flashed the red lights on Tuesday morning, saying it ...

Apr 15, 2025 - 14:42
 0
Mural Oncology ends clinical development, lays off most workers
Boston and Dublin biotech Mural Oncology is laying off nearly all of its employees and ending clinical development of its IL-2 drug nemvaleukin alfa. The biotech flashed the red lights on Tuesday morning, saying it ...